Table 2 The effects of OEA supplementation on the FBS and lipid profile biomarkers in obese people (n = 56)
Variables | Intervention group (n = 27) | Placebo Group (n = 29) | Mean Diff (95% CI) pb |
|---|---|---|---|
FBS | |||
  Before | 91.62 (18.94) | 85.86 (20.18) | 0.96 (-9.69 to 11.61) 0.857 |
   After | 90.07 (19.4) | 91.03 (20.36) | |
   Mean Diff (95% CI)    p a | -1.55 (-6.10 to 2.99) 0.489 | 5.17 (-4.47 to 10.81) 0.071 | |
TC | |||
   Before | 173.96 (32.58) | 178.48 (37.38) | -1.38 (-20.93 to 18.16) 0.888 |
   After | 170.59 (33.29) | 169.20 (39.18) | |
   Mean Diff (95% CI)    p a | -3.37 (-10.86 to 4.11) 0.363 | -9.27 (-20.17 to 1.62) 0.092 | |
TG | |||
   Before | 166.29 (70.01) | 175.93 (74.00) | 31.41 (0.56 to 62.09) 0.044 |
   After | 142.22 (48.05) | 173.55 (64.85) | |
   Mean Diff (95% CI)    p a | -24.07 (-47.85 to -0.29) 0.047 | -2.37 (-32.20 to -27.44) 0.871 | |
LDL-C | |||
   Before | 90.68 (32.65) | 98.55 (31.44) | -2.93 (-19.51 to 13.63) 0.724 |
   After | 96.09 (31.41) | 93.15 (30.43) | |
   Mean Diff (95% CI)    p a | 5.40 (-7.39 to 18.21) 0.393 | -5.39 (-15.57 to 4.79) 0.287 | |
HDL-C | |||
   Before | 48.74 (10.54) | 47.31 (7.87) | 0.08 (-5.69 to 5.85) 0.978 |
   After | 47.33 (12.10) | 47.41 (9.30) | |
   Mean Diff (95% CI)    p a | -1.40 (-4.65 to 1.84) 0.382 | 0.10 (-2.75 to 2.96) 0.941 | |